Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
<jats:p>With an estimated 25% of the global population infected with <jats:italic>Mycobacterium tuberculosis</jats:italic> (<jats:italic>Mtb</jats:italic>), tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral immunity following TB treatmen...
Main Authors: | Grace, Patricia S, Dolatshahi, Sepideh, Lu, Lenette L, Cain, Adam, Palmieri, Fabrizio, Petrone, Linda, Fortune, Sarah M, Ottenhoff, Tom HM, Lauffenburger, Douglas A, Goletti, Delia, Joosten, Simone A, Alter, Galit |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media SA
2021
|
Online Access: | https://hdl.handle.net/1721.1/136134 |
Similar Items
-
Antibody Subclass and Glycosylation Shift Following Effective TB Treatment
by: Grace, Patricia S, et al.
Published: (2022) -
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis
by: Joosten, SA, et al.
Published: (2013) -
Unique patterns of glycosylation in immunoglobulin subclass G4‐related disease and primary sclerosing cholangitis
by: Culver, E, et al.
Published: (2018) -
Crystal structure of Anoxybacillus α-amylase provides insights into maltose binding of a new glycosyl hydrolase subclass
by: Chai, Kian Piaw, et al.
Published: (2016) -
Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors
by: Sadanand, Saheli, et al.
Published: (2019)